Compassionate use is a treatment option that allows the use of an unauthorised medicine. Under strict conditions, products in development can be made available to groups of patients who have a disease with no satisfactory authorised therapies and who cannot enter clinical trials.
View this resource Bookmark this resource
EU Compassionate Use Programs
Published by IRDiRC
Research and Drug DevelopmentRegulatory AffairsClinical DevelopmentOrphan DrugEarly Access SupportEuropean UnionCompassionate UseEMA Compassionate Use